Eike Steidl

9PUBLICATIONS
15CO-AUTHORS
Cell physiologyMedical infection agents (incl. prions)Developmental genetics (incl. sex determination)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 15, 2025
Toward Noninvasive High-Resolution In Vivo pH Mapping in Brain Tumors by <sup>31</sup>P-Informed deepCEST MRI.

Jan-Rüdiger Schüre, Junaid Rajput, Manoj Shrestha

|Oct 08, 2021
Heterotopia in Individuals with 22q11.2 Deletion Syndrome.

E Neuhaus, E Hattingen, S Breuer

|Feb 04, 2021
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.

Eike Steidl, Katharina Filipski, Pia S Zeiner

|Nov 26, 2020
Sequential implementation of DSC-MR perfusion and dynamic [<sup>18</sup>F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.

Eike Steidl, Karl-Josef Langen, Sarah Abu Hmeidan

Pageof 2